Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Gastrointestinal neuromuscular disease v1.24 MIR145 Zornitza Stark Tag non-coding gene tag was added to gene: MIR145.
Gastrointestinal neuromuscular disease v1.20 MIR145 Zornitza Stark Marked gene: MIR145 as ready
Gastrointestinal neuromuscular disease v1.20 MIR145 Zornitza Stark Gene: mir145 has been classified as Red List (Low Evidence).
Gastrointestinal neuromuscular disease v1.20 MIR145 Zornitza Stark Classified gene: MIR145 as Red List (low evidence)
Gastrointestinal neuromuscular disease v1.20 MIR145 Zornitza Stark Gene: mir145 has been classified as Red List (Low Evidence).
Gastrointestinal neuromuscular disease v1.19 MIR145 Lucy Spencer gene: MIR145 was added
gene: MIR145 was added to Gastrointestinal neuromuscular disease. Sources: Literature
Mode of inheritance for gene: MIR145 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Publications for gene: MIR145 were set to 36649075
Phenotypes for gene: MIR145 were set to multisystemic smooth muscle dysfunction syndrome (MONDO:0013452)
Review for gene: MIR145 was set to RED
Added comment: PMID: 36649075- a patient whose fetal ultrasound revealed polyhydramnios, enlarged abdomenand bladder, and prune belly syndrome. During infancy/childhood profound gastrointestinal dysmotility, cerebrovascular disease, and multiple strokes. Described as a multisystemic smooth muscle dysfunction syndrome. Patient was found to have a de novo SNP in MIR145 NR_029686.1:n.18C>A. The MIR145transcript is processed into two microRNAs, with the variant position at nucleotide 3 of miR-145-5p.

Transfection of an siRNA against mutant miR145-5p induced a notable decrease in the expression of several cytoskeletal proteins including transgelin, calponin, and importantly, smooth muscle actin. Hybridization analysis and miR RNA-seq demonstrated a decrease in expression of miR145-5p in the presence of mutant miR145-5p. RNA-seq showed that the differentially expressed genes were substantially different between patient and control fibroblasts.
Sources: Literature